XML 31 R20.htm IDEA: XBRL DOCUMENT v3.20.2
SHAREHOLDERS' EQUITY (Issuance of Shares) (Details)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Apr. 14, 2020
shares
Oct. 10, 2018
USD ($)
$ / shares
Jun. 14, 2018
$ / shares
shares
Mar. 16, 2020
$ / shares
shares
Jun. 19, 2018
USD ($)
May 25, 2018
USD ($)
Jun. 30, 2020
USD ($)
shares
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
shares
Jun. 30, 2020
₪ / shares
shares
Dec. 31, 2019
₪ / shares
shares
May 25, 2018
₪ / shares
Ordinary shares, par value | ₪ / shares                   ₪ 0.01 ₪ 0.01  
Ordinary shares, shares authorized | shares                   200,000,000 200,000,000  
Warrants purchase to ordinary shares | shares                   3,504,061    
Expected dividend yield             0.00% 0.00%        
Deferred participation of BMS in R&D expenses             $ 4,121          
Proceeds from warrant exercised             16,609        
Warrants purchase to ordinary shares remain outstanding | shares                   749,104    
At The Market Offering Program [Member]                        
Ordinary shares, par value | ₪ / shares                       ₪ 0.01
Proceeds from issuance of common stock           $ 25,000     $ 22,914      
Issuance of shares, net, shares | shares                 7,245,268      
Issuance expenses                 $ 781      
Agreement [Member] | Registered direct offering [Member]                        
Proceeds from issuance of common stock         $ 19,767              
Issuance expenses         $ 1,233              
Ordinary shares, shares authorized | shares     5,316,457                  
Warrants purchase to ordinary shares | shares     4,253,165                  
Offering price per share | $ / shares     $ 3.95                  
Exercise price of warrants | $ / shares     $ 4.74                  
Expiration period of warrants     5 years                  
Master Clinical Agreement [Member]                        
Proceeds from issuance of common stock   $ 2,424,243                    
Offering price per share | $ / shares   $ 4.95                    
Equity investment   $ 12,000                    
Percentage of closing price   33.00%                    
Collaborative Arrangements [Member]                        
Proceeds from issuance of common stock             7,788          
Issuance expenses             $ 91          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member]                        
Issuance of shares, net, shares | shares       8,333,334     8,816,339          
Issuance expenses             $ 5,200          
Offering price per share | $ / shares       $ 9.00                
Proceeds from ordinary shares in offering             $ 74,147          
SVB Leerink LLC and Stifel, Nicolaus & Company [Member] | Underwriters [Member]                        
Issuance of shares, net, shares | shares 483,005                      
Offering price per share | $ / shares       $ 8.46